Market Place
Sourcing Support
Renalytix And Steno Partner For KidneyIntelX Platform Expansion Beyond US
11 Jul 2024 //
GLOBENEWSWIRE
Renalytix Submits Hearing Request to Nasdaq Hearings Panel
27 Jun 2024 //
GLOBENEWSWIRE
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024
15 May 2024 //
GLOBENEWSWIRE
Renalytix Q3 FY2024 Results On May 15
09 May 2024 //
GLOBENEWSWIRE
Renalytix Announces Financing with Expected Size of up to $4 Million
08 Apr 2024 //
GLOBENEWSWIRE
Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024
15 Feb 2024 //
GLOBENEWSWIRE
Renalytix to Participate in the BTIG MedTech Conference
09 Feb 2024 //
GLOBENEWSWIRE
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024
14 Nov 2023 //
GLOBENEWSWIRE
Renalytix to Report Financial Results for First Quarter Fiscal Year 2024
07 Nov 2023 //
GLOBENEWSWIRE
US Patent Office Allows Patent Claims for Property Licensed to Renalytix
06 Oct 2023 //
GLOBENEWSWIRE
Renalytix Reports Full Year Fiscal 2023 Results
28 Sep 2023 //
GLOBENEWSWIRE
Renalytix to Report Financial Results for Q4 and Full Year Fiscal 2023
25 Sep 2023 //
GLOBENEWSWIRE
Renalytix Appoints Senior Executive Howard Doran as Chief Business Officer
07 Sep 2023 //
GLOBENEWSWIRE
Renalytix Advisory Board Formed to Support Broadening Use of KidneyintelX.dkd
03 Aug 2023 //
GLOBENEWSWIRE
Renalytix Announces Middle East Distribution Agreement with Vector Pharma
21 Jul 2023 //
GLOBENEWSWIRE
KidneyIntelX Evidence Released at 83rd Association Scientific Sessions
07 Jul 2023 //
GLOBENEWSWIRE
Renalytix nabs FDA nod for AI-powered kidney disease test
06 Jul 2023 //
FIERCE BIOTECH
Renalytix Appoints Financial Executive Catherine Coste to its Board of Directors
03 Jul 2023 //
GLOBENEWSWIRE
FDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess
29 Jun 2023 //
GLOBENEWSWIRE
KidneyIntelX„¢ Clinical Decision Impact / Validation and Health Economic Data
15 Jun 2023 //
GLOBENEWSWIRE
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2023
09 Jun 2023 //
GLOBENEWSWIRE
Renalytix to Report Third Quarter Fiscal Year 2023 Financial Results on June 9
05 Jun 2023 //
GLOBENEWSWIRE
Renalytix selects EVERSANA® to expand commercialization of KidneyIntelX
25 May 2023 //
GLOBENEWSWIRE
New Published Real-World Evidence Shows KidneyIntelXâ„¢ Utility
19 Apr 2023 //
GLOBENEWSWIRE
Renalytix Reports Second Quarter & First Half Fiscal Year 2023 Financial Results
30 Mar 2023 //
GLOBENEWSWIRE
Renalytix to Report Q2 and First Half Fiscal Year 2023 Financial Results
22 Mar 2023 //
GLOBENEWSWIRE
Renalytix to Participate in the BTIG MedTech, Digital Health Conference
09 Feb 2023 //
GLOBENEWSWIRE
Renalytix and Partners Awarded $10 Million Horizon Europe Grant
26 Jan 2023 //
GLOBENEWSWIRE
Renalytix Completes Agreement to Integrate KidneyIntelX Testing
09 Jan 2023 //
GLOBENEWSWIRE
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2023
30 Nov 2022 //
GLOBENEWSWIRE
Renalytix to Report Financial Results for First Quarter Fiscal Year
22 Nov 2022 //
GLOBENEWSWIRE
Renalytix to Report Financial Results for Fourth Quarter
24 Oct 2022 //
GLOBENEWSWIRE
KidneyIntelX Clinical Utility and Health Economics Validated in Multiple Data
17 Oct 2022 //
GLOBENEWSWIRE
Renalytix Announces Change to Board of Directors
20 Sep 2022 //
GLOBENEWSWIRE
Renalytix to Present at H.C. Wainwright 24th Annual Global Investment Conference
08 Sep 2022 //
GLOBENEWSWIRE
Data Results Published in American Journal of Managed Care of KidneyIntelX
08 Aug 2022 //
GLOBENEWSWIRE
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2022
30 Jun 2022 //
GLOBENEWSWIRE
Renalytix to Report Financial Results for Third Quarter Fiscal 2022 on June 30
23 Jun 2022 //
GLOBENEWSWIRE
Renalytix to Present at 42nd Annual William Blair Growth Stock Conference
08 Jun 2022 //
GLOBENEWSWIRE
Renalytix plc successful completion of $30.0 million financing package
08 Apr 2022 //
GLOBENEWSWIRE
Renalytix plc Issue of shares
08 Apr 2022 //
GLOBENEWSWIRE
Renalytix announces a $30.0 million financing package
31 Mar 2022 //
GLOBENEWSWIRE
Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2022
31 Mar 2022 //
GLOBENEWSWIRE
Confirmation of Appointment of Timothy Scannell to Renalytix Board of Directors
30 Mar 2022 //
GLOBENEWSWIRE
Renalytix Reaches Enrollment Milestone for Building KidneyIntelX
29 Mar 2022 //
GLOBENEWSWIRE
Renalytix Launches myIntelX
09 Mar 2022 //
GLOBENEWSWIRE
Renalytix to Present at Cowen 42nd Annual Health Care Conference
22 Feb 2022 //
GLOBENEWSWIRE
